SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories
In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director
About Face; NCI To Keep Preclinical AIDS Drug Development
EORTC Places Same Number on Phase 2-3 Trials As In U.S.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









